Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debra J Ehrlich

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Clinical Movement Disorders|August 16, 2019
The phenomenology and treatment of idiopathic adult-onset truncal dystonia: a retrospective reviewDebra J Ehrlich, Steven J Frucht
Journal of Clinical Movement Disorders|June 27, 2017
Functional neuroimaging and chorea: a systematic reviewDebra J Ehrlich, Ruth H Walker
Parkinsonism & Related Disorders|August 3, 2025
Olfactory network reorganization in Parkinson's diseaseMohammed Saqib, Laura Pesantez Pacheco, Debra J Ehrlich, et al.
Molecular and Cellular Neurosciences|December 8, 2006
Molecular alterations in the cerebellum of the plasma membrane calcium ATPase 2 (PMCA2)-null mouse indicate abnormalities in Purkinje neuronsMichael P Kurnellas, Amanda K Lee, Hong Li, et al.
Movement Disorders Clinical Practice|April 18, 2023
Electrophysiological Characterization of a <i>MYH7</i> Variant with Tremor PhenotypeFelipe Vial, Patrick McGurrin, Thomas Osterholt, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 6, 2026
A Phase 1 Study of Convection-Enhanced Delivery of Intraputaminal AAV2-GDNF in Advanced Parkinson's DiseaseJohn D Heiss, Debra J Ehrlich, Codrin Lungu, et al.
BMC Neurology|April 2, 2024
A randomized feasibility trial of medium chain triglyceride-supplemented ketogenic diet in people with Parkinson's diseaseAlexander H Choi, Melanie Delgado, Kong Y Chen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 12, 2022
Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson's diseaseMatthew T Rocco, Asad S Akhter, Debra J Ehrlich, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2023
Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson's diseaseMatthew T Rocco, Asad S Akhter, Debra J Ehrlich, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 31, 2019
Trial of magnetic resonance-guided putaminal gene therapy for advanced Parkinson's diseaseJohn D Heiss, Codrin Lungu, Dima A Hammoud, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Clinical Movement Disorders|August 16, 2019
The phenomenology and treatment of idiopathic adult-onset truncal dystonia: a retrospective reviewDebra J Ehrlich, Steven J Frucht
Journal of Clinical Movement Disorders|June 27, 2017
Functional neuroimaging and chorea: a systematic reviewDebra J Ehrlich, Ruth H Walker
Parkinsonism & Related Disorders|August 3, 2025
Olfactory network reorganization in Parkinson's diseaseMohammed Saqib, Laura Pesantez Pacheco, Debra J Ehrlich, et al.
Molecular and Cellular Neurosciences|December 8, 2006
Molecular alterations in the cerebellum of the plasma membrane calcium ATPase 2 (PMCA2)-null mouse indicate abnormalities in Purkinje neuronsMichael P Kurnellas, Amanda K Lee, Hong Li, et al.
Movement Disorders Clinical Practice|April 18, 2023
Electrophysiological Characterization of a <i>MYH7</i> Variant with Tremor PhenotypeFelipe Vial, Patrick McGurrin, Thomas Osterholt, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 6, 2026
A Phase 1 Study of Convection-Enhanced Delivery of Intraputaminal AAV2-GDNF in Advanced Parkinson's DiseaseJohn D Heiss, Debra J Ehrlich, Codrin Lungu, et al.
BMC Neurology|April 2, 2024
A randomized feasibility trial of medium chain triglyceride-supplemented ketogenic diet in people with Parkinson's diseaseAlexander H Choi, Melanie Delgado, Kong Y Chen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 12, 2022
Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson's diseaseMatthew T Rocco, Asad S Akhter, Debra J Ehrlich, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2023
Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson's diseaseMatthew T Rocco, Asad S Akhter, Debra J Ehrlich, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 31, 2019
Trial of magnetic resonance-guided putaminal gene therapy for advanced Parkinson's diseaseJohn D Heiss, Codrin Lungu, Dima A Hammoud, et al.
Pageof 2